The decision to expand use of the True Colours platform for people with ulcerative colitis follows a successful six-month trial involving around 60 patients at the John Radcliffe Hospital, supported by the National Institute of Health Research (NIHR) Oxford Biomedical Research Centre (BRC). Alissa Walsh, who carried out the trial, is a Clinical Research Fellow in Gastroenterology in the Translational Gastroenterology Unit in the Nuffield Department of Medicine.